Advertisement
Journal Home
Search for

Volume 46, Issue 1, Pages 14-18 (January 2010)


View previous. 7 of 17 View next.

Paraneoplastic syndromes in patients with oral cancer

C. ToroaCorresponding Author Informationemail address, A. Rinaldob, C.E. Silverc, M. Politia, A. Ferlitob

Received 21 September 2009; received in revised form 29 September 2009; accepted 30 September 2009. published online 23 November 2009.

Summary 

The diagnosis of a paraneoplastic syndrome (PNS) may precede, follow or be concurrent with the diagnosis of a malignant tumor. There is increasing knowledge of association between PNS and head and neck cancers, but the relationship between oral cancer and paraneoplastic disease has not been previously investigated. PNS associated with head and neck cancer can be divided into six main groups: endocrine, cutaneous or dermatologic, hematologic, osteoarticular or rheumatologic, neurologic, and ocular syndromes. We have comprehensively reviewed the literature to evaluate the incidence of occurrence of PNS with oral cancer, and conclude that only endocrine and dermatologic PNS have been associated with oral cancer. Humoral hypercalcemia is the most frequent PNS related to oral cancer, and has a negative prognostic significance. Dermatologic PNS are less common, but when they occur, they may precede the diagnosis of the oral tumor. Awareness of these conditions is important for clinicians who deal with cancer.

a Department of Surgical Sciences, Maxillofacial Surgery Clinic, University-Hospital of Udine, Udine, Italy

b Department of Surgical Sciences, ENT Clinic, University-Hospital of Udine, Udine, Italy

c Departments of Surgery and Otolaryngology-Head and Neck Surgery, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA

Corresponding Author InformationCorresponding author. Address: Maxillofacial Surgery Clinic, University-Hospital “S. Maria della Misericordia” of Udine, P.le S. Maria della Misericordia, 33100 Udine, Italy. Tel.: +39 (0) 432/559455; fax: +39 (0) 432/559868.

PII: S1368-8375(09)00937-3

doi:10.1016/j.oraloncology.2009.09.007


View previous. 7 of 17 View next.

Advertisement